Literature DB >> 11281194

Immunohistochemical analysis of distribution of RON receptor tyrosine kinase in human digestive organs.

T Okino1, H Egami, H Ohmachi, E Takai, Y Tamori, A Nakagawa, S Nakano, O Sakamoto, T Suda, M Ogawa.   

Abstract

The immunohistochemical distribution of RON receptor tyrosine kinase in digestive organs of both human fetus and adult, including the esophagus, stomach, duodenum, small intestine, colon, rectum, liver, gallbladder, pancreas, and spleen, was investigated semiquantitively using an affinity-purified rabbit polyclonal antibody. RON was observed to be widely distributed throughout various digestive organs and cell types in humans. The immunoreactivity for RON was observed in the epithelium of the esophagus, small intestine, colon, hepatocytes, Kupffer cells, and splenic macrophages both in the adult and the fetus, suggesting that the MSP/RON signaling pathway possesses the proper biological properties to possibly be involved in morphogenesis or differentiation of cells in these organs and cell types. Several organs differed in immunoreactivity between adult and fetus. No immunoreactive cells were found in the pancreas of adults; however, immunoreactivity was observed in acinar cells and in some of the duct or ductular cells and endocrine cells of the islet of the fetus. Similarly, immunoreactivity was not observed in gastric mucosa except in the intestinal metaplastic cells in adults; however, immunoreactivity was found in the foveolar epithelium of the stomach of the fetus. Although the biological significance of RON in malignancy is unclear, the presence of RON immunoreactivity in the fetus and it lack in the adult may indicate that RON is a oncofetal substance in human pancreas and stomach.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11281194     DOI: 10.1023/a:1005673420464

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  16 in total

1.  Light microscopic immunohistochemical analysis of the distribution of group II phospholipase A2 in human digestive organs.

Authors:  H Kiyohara; H Egami; Y Shibata; K Murata; S Ohshima; M Ogawa
Journal:  J Histochem Cytochem       Date:  1992-11       Impact factor: 2.479

2.  Role of macrophage-stimulating protein and its receptor, RON tyrosine kinase, in ciliary motility.

Authors:  O Sakamoto; A Iwama; R Amitani; T Takehara; N Yamaguchi; T Yamamoto; K Masuyama; T Yamanaka; M Ando; T Suda
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

3.  STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family.

Authors:  A Iwama; N Yamaguchi; T Suda
Journal:  EMBO J       Date:  1996-11-01       Impact factor: 11.598

4.  A splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotype.

Authors:  C Collesi; M M Santoro; G Gaudino; P M Comoglio
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

5.  Molecular cloning of rat macrophage-stimulating protein and its involvement in the male reproductive system.

Authors:  K Ohshiro; A Iwama; K Matsuno; T Ezaki; O Sakamoto; I Hamaguchi; N Takasu; T Suda
Journal:  Biochem Biophys Res Commun       Date:  1996-10-03       Impact factor: 3.575

6.  Cloning, sequencing, and expression of human macrophage stimulating protein (MSP, MST1) confirms MSP as a member of the family of kringle proteins and locates the MSP gene on chromosome 3.

Authors:  T Yoshimura; N Yuhki; M H Wang; A Skeel; E J Leonard
Journal:  J Biol Chem       Date:  1993-07-25       Impact factor: 5.157

7.  Action and target cell specificity of human macrophage-stimulating protein (MSP).

Authors:  A Skeel; E J Leonard
Journal:  J Immunol       Date:  1994-05-01       Impact factor: 5.422

8.  Histochemical characterization of different types of intestinal metaplasia in gastric mucosa.

Authors:  D I Segura; C Montero
Journal:  Cancer       Date:  1983-08-01       Impact factor: 6.860

9.  Induction of intestinal metaplasia and carcinoma in the glandular stomach of rats by N-alkyl-N'-nitro-N-nitrosoguanidines.

Authors:  N Matsukura; T Kawachi; T Sugimura; M Nakadate; T Hirota
Journal:  Gan       Date:  1979-04

10.  RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP.

Authors:  G Gaudino; A Follenzi; L Naldini; C Collesi; M Santoro; K A Gallo; P J Godowski; P M Comoglio
Journal:  EMBO J       Date:  1994-08-01       Impact factor: 11.598

View more
  9 in total

1.  Role of STK in mouse liver macrophage and endothelial cell responsiveness during acute endotoxemia.

Authors:  Debra L Laskin; Li Chen; Pamela A Hankey; Jeffrey D Laskin
Journal:  J Leukoc Biol       Date:  2010-05-07       Impact factor: 4.962

2.  Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors.

Authors:  Patricia M LoRusso; Mrinal Gounder; Shadia I Jalal; Valérie André; Siva Rama Prasad Kambhampati; Nick Loizos; Jennifer Hall; Timothy R Holzer; Aejaz Nasir; Jan Cosaert; John Kauh; E Gabriela Chiorean
Journal:  Invest New Drugs       Date:  2017-02-04       Impact factor: 3.850

3.  RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma.

Authors:  Daniel V T Catenacci; Gustavo Cervantes; Soheil Yala; Erik A Nelson; Essam El-Hashani; Rajani Kanteti; Mohamed El Dinali; Rifat Hasina; Johannes Brägelmann; Tanguy Seiwert; Michele Sanicola; Les Henderson; Tatyana A Grushko; Olufunmilayo Olopade; Theodore Karrison; Yung-Jue Bang; Woo Ho Kim; Maria Tretiakova; Everett Vokes; David A Frank; Hedy L Kindler; Heather Huet; Ravi Salgia
Journal:  Cancer Biol Ther       Date:  2011-07-01       Impact factor: 4.742

4.  The Ron receptor tyrosine kinase is not required for adenoma formation in Apc(Min/+) mice.

Authors:  Sara E Meyer; Susan E Waltz; Kathleen H Goss
Journal:  Mol Carcinog       Date:  2009-11       Impact factor: 4.784

5.  Ron receptor signaling is protective against DSS-induced colitis in mice.

Authors:  Rishikesh M Kulkarni; William D Stuart; Devikala Gurusamy; Susan E Waltz
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-04-17       Impact factor: 4.052

6.  Ron receptor-dependent gene regulation of Kupffer cells during endotoxemia.

Authors:  Rishikesh M Kulkarni; William D Stuart; Susan E Waltz
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2014-06

7.  Therapeutic Considerations for Ron Receptor Expression in Prostate Cancer.

Authors:  Nicholas E Brown; Camille Sullivan; Susan E Waltz
Journal:  EMS Cancer Sci J       Date:  2018-07-30

8.  Functional consequences of the macrophage stimulating protein 689C inflammatory bowel disease risk allele.

Authors:  Steven E Kauder; Lydia Santell; Elaine Mai; Lilyan Y Wright; Elizabeth Luis; Elsa N N'Diaye; Jeff Lutman; Navneet Ratti; Susan M Sa; Henry R Maun; Eric Stefanich; Lino C Gonzalez; Robert R Graham; Lauri Diehl; William A Faubion; Mary E Keir; Judy Young; Amitabha Chaudhuri; Robert A Lazarus; Jackson G Egen
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

9.  Expression of the RON receptor tyrosine kinase and its association with gastric carcinoma versus normal gastric tissues.

Authors:  Donghui Zhou; Gang Pan; Chen Zheng; Jingjing Zheng; Liping Yian; Xiaodong Teng
Journal:  BMC Cancer       Date:  2008-11-28       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.